Balance Sheet Account Details

6 Months Ended

Jun. 30, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Cash, Cash Equivalents and Restricted Cash

Restricted cash as of June 30, 2018 and December 31, 2017 represents a standby letter of credit for the Company’s building lease in lieu of a security deposit during the term of such lease. There is a requirement to maintain $0.9 million of cash collateral in an account pledged as security for such letter of credit.

Accrued Expenses

Accrued expenses consist of the following (in thousands):



	June 30, 2018		December 31, 2017
Accrued clinical trials	$	1,972	$	577
Accrued interest expense	1,641		—
Accrued other	3,339		126
Total accrued expenses	$	6,952	$	703